Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11986 | 876 | 43.8 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2377 | 3822 | NON NEURONAL ACETYLCHOLINE//CHOLINERGIC ANTI INFLAMMATORY PATHWAY//HEMICHOLINIUM 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLPTM1L | Author keyword | 15 | 73% | 1% | 11 |
2 | CHRNA3 | Author keyword | 12 | 53% | 2% | 16 |
3 | TERT CLPTM1L | Author keyword | 12 | 86% | 1% | 6 |
4 | CHRNA5 | Author keyword | 10 | 48% | 2% | 15 |
5 | 5P1533 | Author keyword | 6 | 80% | 0% | 4 |
6 | CHRNB4 | Author keyword | 5 | 63% | 1% | 5 |
7 | NICOTINIC RECEPTOR GENES | Author keyword | 4 | 67% | 0% | 4 |
8 | CHOLINERGIC NICOTINIC RECEPTORS | Author keyword | 3 | 100% | 0% | 3 |
9 | CHRNA | Author keyword | 3 | 100% | 0% | 3 |
10 | CHRNA5 A3 B4 | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLPTM1L | 15 | 73% | 1% | 11 | Search CLPTM1L | Search CLPTM1L |
2 | CHRNA3 | 12 | 53% | 2% | 16 | Search CHRNA3 | Search CHRNA3 |
3 | TERT CLPTM1L | 12 | 86% | 1% | 6 | Search TERT+CLPTM1L | Search TERT+CLPTM1L |
4 | CHRNA5 | 10 | 48% | 2% | 15 | Search CHRNA5 | Search CHRNA5 |
5 | 5P1533 | 6 | 80% | 0% | 4 | Search 5P1533 | Search 5P1533 |
6 | CHRNB4 | 5 | 63% | 1% | 5 | Search CHRNB4 | Search CHRNB4 |
7 | NICOTINIC RECEPTOR GENES | 4 | 67% | 0% | 4 | Search NICOTINIC+RECEPTOR+GENES | Search NICOTINIC+RECEPTOR+GENES |
8 | CHOLINERGIC NICOTINIC RECEPTORS | 3 | 100% | 0% | 3 | Search CHOLINERGIC+NICOTINIC+RECEPTORS | Search CHOLINERGIC+NICOTINIC+RECEPTORS |
9 | CHRNA | 3 | 100% | 0% | 3 | Search CHRNA | Search CHRNA |
10 | CHRNA5 A3 B4 | 3 | 100% | 0% | 3 | Search CHRNA5+A3+B4 | Search CHRNA5+A3+B4 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 5P1533 | 54 | 60% | 7% | 59 |
2 | 15Q25 | 37 | 73% | 3% | 29 |
3 | CHROMOSOME 15Q25 | 31 | 92% | 1% | 12 |
4 | HEAVY SMOKING | 27 | 51% | 4% | 37 |
5 | AFFECT GROWTH REGULATION | 26 | 100% | 1% | 11 |
6 | MEDIATED TOBACCO TOXICITY | 11 | 54% | 2% | 14 |
7 | CHRNA5 CHRNA3 CHRNB4 | 11 | 78% | 1% | 7 |
8 | TERT CLPTM1L | 11 | 78% | 1% | 7 |
9 | 15Q251 | 8 | 62% | 1% | 8 |
10 | TOBACCO SPECIFIC TOXICANTS | 7 | 67% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers | 2014 | 17 | 81 | 58% |
Connections of nicotine to cancer | 2014 | 10 | 163 | 52% |
Association Between Genetic Variants on Chromosome 15q25 Locus and Objective Measures of Tobacco Exposure | 2012 | 38 | 51 | 53% |
Association of the CHRNA5-A3-B4 Gene Cluster With Heaviness of Smoking: A Meta-Analysis | 2011 | 23 | 50 | 76% |
Telomerase Reverse Transcriptase Locus Polymorphisms and Cancer Risk: A Field Synopsis and Meta-Analysis | 2012 | 44 | 90 | 32% |
Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer | 2011 | 25 | 107 | 59% |
Genetic Vulnerability and Susceptibility to Substance Dependence | 2011 | 45 | 62 | 37% |
Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25 | 2010 | 45 | 29 | 66% |
A glimpse into the future - Personalized medicine for smoking cessation | 2014 | 2 | 54 | 67% |
From Men to Mice: CHRNA5/CHRNA3, Smoking Behavior and Disease | 2012 | 12 | 73 | 70% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANESTHESIOL BASIC SCI | 2 | 67% | 0.2% | 2 |
2 | CANC TRANSLAT MED | 2 | 67% | 0.2% | 2 |
3 | AFFILIATED CHANGNING MENTAL HLTH | 2 | 29% | 0.6% | 5 |
4 | SYST PROACHES NON COMMUNICABLE DIS | 2 | 29% | 0.6% | 5 |
5 | WUHAN IRON STEEL GRP | 2 | 43% | 0.3% | 3 |
6 | MED EMBRYOL ISTOL | 1 | 100% | 0.2% | 2 |
7 | ALCOHOL DRUG PROGRAMS | 1 | 40% | 0.2% | 2 |
8 | ANIM IL UNIT | 1 | 22% | 0.5% | 4 |
9 | LUNG CANC UNIT | 1 | 12% | 0.9% | 8 |
10 | SUBSTANCE DEPENDENCE | 1 | 25% | 0.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192596 | CHOLINERGIC ANTI INFLAMMATORY PATHWAY//INFLAMMATORY REFLEX//NON NEURONAL ACETYLCHOLINE |
2 | 0.0000178520 | ONCOL AH ROFFO//FLUORESCENCE VOLTAGE MEASUREMENT//HIV IGA |
3 | 0.0000149805 | DRD2//REWARD DEFICIENCY SYNDROME RDS//D2 DOPAMINE RECEPTOR GENE |
4 | 0.0000140242 | NEONEUROGENESIS//METASTASIS FORMATION//BP6 TU2 FIBROSARCOMA CELLS |
5 | 0.0000115338 | COPD RELATED PHENOTYPES//IREB2//FAM13A |
6 | 0.0000093092 | PSYCHOSOCIAL BEHAV MED PROGRAM//ABSTINENCE RATES//UER LYON SUD CHARLES MERIEUX |
7 | 0.0000079735 | NICOTINE//ALPHA 7//NICOTINIC RECEPTOR |
8 | 0.0000078537 | GABRA2//GABRG1//NEUROBEHAVIOR DISINHIBITION |
9 | 0.0000078186 | SMOKERS PARADOX//INTERNAL MED CARDIOL ANESTHESIOL 2//ENVIRONM SMOKING INDUCED DIS |
10 | 0.0000077294 | TOBACCO SPECIFIC N NITROSAMINES//NNK//NNAL |